Canntab Therapeutics Limited
Focussed on providing a range of wellness products to the global cannabis market, Canntab Therapeutics has partnerships with Emblem Corp. and Cann Global Limited. Their flagship product line includes oral-dose cannabinoid and terpene blends, with a number of patents to support future developments. The company’s pharmaceutical grade formulations are aimed at treating many conditions.
Focussed on providing a range of wellness products to the global cannabis market, Canntab Therapeutics has partnerships with Emblem Corp. and Cann Global Limited. Their flagship product line includes oral-dose cannabinoid and terpene blends, with a number of patents to support future developments. The company’s pharmaceutical grade formulations are aimed at treating many conditions.
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
PILL |
$435
|
12.43% |
$0.2542
|
| CTABF |
Total volume
$3,066
|
87.57% |
Stock price
$0.2920
|
